NO954389D0 - Fosfonosulfonat-squalensyntetase-inhibitor-salter og fremgangsmåte - Google Patents
Fosfonosulfonat-squalensyntetase-inhibitor-salter og fremgangsmåteInfo
- Publication number
- NO954389D0 NO954389D0 NO954389A NO954389A NO954389D0 NO 954389 D0 NO954389 D0 NO 954389D0 NO 954389 A NO954389 A NO 954389A NO 954389 A NO954389 A NO 954389A NO 954389 D0 NO954389 D0 NO 954389D0
- Authority
- NO
- Norway
- Prior art keywords
- squalene synthetase
- synthetase inhibitor
- inhibitor salts
- phosphonosulfonate
- phosphonosulfonate squalene
- Prior art date
Links
- LQHYUUBBIJGBNR-UHFFFAOYSA-N OP(O)(=O)S(O)(=O)=O Chemical compound OP(O)(=O)S(O)(=O)=O LQHYUUBBIJGBNR-UHFFFAOYSA-N 0.000 title 1
- 229940123495 Squalene synthetase inhibitor Drugs 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
- 239000004059 squalene synthase inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4056—Esters of arylalkanephosphonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4071—Esters thereof the ester moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4075—Esters with hydroxyalkyl compounds
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US33366194A | 1994-11-03 | 1994-11-03 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO954389D0 true NO954389D0 (no) | 1995-11-02 |
| NO954389L NO954389L (no) | 1996-05-06 |
Family
ID=23303735
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO954389A NO954389L (no) | 1994-11-03 | 1995-11-02 | Fosfonosulfonat-squalensyntetase-inhibitor-salter og fremgangsmåte |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0710665A1 (no) |
| JP (1) | JPH08208672A (no) |
| KR (1) | KR960017680A (no) |
| CN (1) | CN1130188A (no) |
| AU (1) | AU3458795A (no) |
| CA (1) | CA2159850A1 (no) |
| CZ (1) | CZ279595A3 (no) |
| FI (1) | FI955256A (no) |
| HU (1) | HUT73140A (no) |
| IL (1) | IL115537A0 (no) |
| NO (1) | NO954389L (no) |
| PL (1) | PL311218A1 (no) |
| TW (1) | TW318852B (no) |
| ZA (1) | ZA959326B (no) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2780974B1 (fr) * | 1998-07-08 | 2001-09-28 | Sod Conseils Rech Applic | Utilisation de derives d'imidazopyrazines pour preparer un medicament destine a traiter les pathologies qui resultent de la formation de la proteine g heterotrimetrique |
| EP1332763A4 (en) * | 2000-11-09 | 2007-03-14 | Takeda Pharmaceutical | HIGH DENSITY AGENT Raising LIPOPROTEIN-CHOLESTEROL RATE |
| AU2006330064B2 (en) | 2005-04-18 | 2012-08-09 | The Regents Of The University Of California | Antimicrobial therapy for bacterial infections |
| KR101385868B1 (ko) * | 2006-05-12 | 2014-04-17 | 유니버시티 오브 일리노이즈 앳 어바나-샴페인 | 세균 감염에 대한 항균 요법 |
| CN101580472B (zh) * | 2009-06-24 | 2013-07-10 | 广西壮族自治区化工研究院 | 1,1'-联-2-萘酚的拆分剂以及拆分方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2107644A1 (en) * | 1992-10-28 | 1994-04-29 | David R. Magnin | .alpha.-phosphonosulfonae squalene synthetase inhibitors and methd |
| US5312814A (en) * | 1992-12-09 | 1994-05-17 | Bristol-Myers Squibb Co. | α-phosphonocarboxylate squalene synthetase inhibitors |
-
1995
- 1995-10-04 CA CA002159850A patent/CA2159850A1/en not_active Abandoned
- 1995-10-06 IL IL11553795A patent/IL115537A0/xx unknown
- 1995-10-25 CZ CZ952795A patent/CZ279595A3/cs unknown
- 1995-10-26 EP EP95307618A patent/EP0710665A1/en not_active Withdrawn
- 1995-10-27 JP JP7280397A patent/JPH08208672A/ja active Pending
- 1995-11-02 TW TW084111593A patent/TW318852B/zh active
- 1995-11-02 FI FI955256A patent/FI955256A/fi not_active Application Discontinuation
- 1995-11-02 AU AU34587/95A patent/AU3458795A/en not_active Abandoned
- 1995-11-02 HU HU9503136A patent/HUT73140A/hu unknown
- 1995-11-02 PL PL95311218A patent/PL311218A1/xx unknown
- 1995-11-02 NO NO954389A patent/NO954389L/no unknown
- 1995-11-03 KR KR1019950039576A patent/KR960017680A/ko not_active Application Discontinuation
- 1995-11-03 ZA ZA959326A patent/ZA959326B/xx unknown
- 1995-11-03 CN CN95119023A patent/CN1130188A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| HU9503136D0 (en) | 1995-12-28 |
| CN1130188A (zh) | 1996-09-04 |
| KR960017680A (ko) | 1996-06-17 |
| HUT73140A (en) | 1996-06-28 |
| IL115537A0 (en) | 1996-01-19 |
| PL311218A1 (en) | 1996-05-13 |
| FI955256A (fi) | 1996-05-04 |
| NO954389L (no) | 1996-05-06 |
| EP0710665A1 (en) | 1996-05-08 |
| FI955256A0 (fi) | 1995-11-02 |
| TW318852B (no) | 1997-11-01 |
| JPH08208672A (ja) | 1996-08-13 |
| CZ279595A3 (en) | 1996-08-14 |
| CA2159850A1 (en) | 1996-05-04 |
| ZA959326B (en) | 1997-05-05 |
| AU3458795A (en) | 1996-05-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO2008002I1 (no) | Protiokonazol og salter derav | |
| DK1095941T3 (da) | Fremgangsmåde og krystalformer for 2-methyl-thieno-benzodiazepin | |
| NO973836L (no) | Benzopyran-inneholdende forbindelser og fremgangsmåte for anvendelse derav | |
| AU3022495A (en) | Alpha-phosphonosulfinate squalene synthetase inhibitors and method | |
| ZA917262B (en) | Novel squalene synthetase inhibitors | |
| NO963858L (no) | Rörleggingsfartöy og fremgangsmåte | |
| ZA923475B (en) | Bisphosphonate squalene synthetase inhibitors and method | |
| NO954690D0 (no) | Intelligent akkompagnementsapparat og fremgangsmåte | |
| NO961793L (no) | Brönnrensesystem og fremgangsmåte | |
| NO965489D0 (no) | Kontrollert denitrifikasjonsprosess og system | |
| NO943763D0 (no) | 4-arylamino-benzopyraner og beslektede forbindelser | |
| AU672245B2 (en) | Alpha-phosphonocarboxylate squalene synthetase inhibitors and method | |
| NO953450D0 (no) | Fremgangsmåte og innretning for trådkapping | |
| NO962072D0 (no) | Fremgangsmåte og anordning for fordamping | |
| LV11325A (lv) | Skvalena sintetazes inhibitori | |
| ZA937388B (en) | Alpha-phosphonosulfonate squalene synthetase inhibitors and method | |
| ZA905481B (en) | Phosphorus-containing squalene synthetase inhibitors and method | |
| NO960397D0 (no) | Gassdrevet mekanisk oscillator og fremgangsmåte | |
| NO954321D0 (no) | 4-aryl-4-hydroksy-tetrahydropyraner og 3-aryl-3-hydroksy-tetrahydrofuraner som 5-lipoksygenase-inhibitorer | |
| NO954389D0 (no) | Fosfonosulfonat-squalensyntetase-inhibitor-salter og fremgangsmåte | |
| DE19580444T1 (de) | Laserbearbeitungsvorrichtung, Laserbearbeitungsverfahren und Hemmsteg-Bearbeitungsverfahren | |
| DK0810947T3 (da) | Indretning og fremgangsmåde i emballeringsmaskine | |
| NO961733D0 (no) | Fremgangsmåte for desinfisering og törking | |
| NO971414D0 (no) | Identifikasjonsmetode og identifikasjonsapparat | |
| NO954597D0 (no) | Fremgangsmåte for sveising og sveiseanordning |